Will Neuralink's valuation hit (HIGH) $100B by December 31?
As of September 5, 2026, the market gives “Will Neuralink's valuation hit (HIGH) $100B by December 31?” a 89% chance of NO.
| YES odds | 11% |
|---|---|
| NO odds | 89% |
| Volume | $31,239 |
| Closes | January 1, 2027 |
Updated September 5, 2026 · Live data from Polymarket
About this market
Secondary market transactions have driven Neuralink’s implied valuation to the $30–43 billion range as of September 2026, up from the $9–9.6 billion post-money level established in its June 2025 Series E round, reflecting sustained secondary trading volumes and bids reaching as high as $60 billion on platforms tracking pre-IPO shares. This re-rating stems from expanded human clinical trials now involving 21 participants, multiple FDA breakthrough device designations for motor and vision applications, and demonstrated patient outcomes in cursor control and communication, all amplified by broader investor enthusiasm for Elon Musk-led AI and robotics assets following SpaceX developments. With zero current revenue and commercialization still years away, market-implied odds hinge on continued trial enrollment momentum and any incremental regulatory or funding milestones through year-end.